Cytodyn Inc (CYDY)

[cowtown jay]

I don't see how CYDY will be able to escape a reverse split, especially if the company is to uplist. But unlike HGEN's 1:5 reverse split, CYDY will likely need a higher ratio.

But I think it's a moot point, until CYDY deals with eliminating the problem they recognized in their recent filing regarding Iliad. It appears that they are working on that.

Also, considering the reverse split was approved by written consent of HGEN's majority shareholders, consisting of company insiders who hold 62% of the company's shares, the share price decline was not likely attributable in a significant way to the reverse split.

Instead, it seems to fit the pattern of many companies who go through the uplisting process. It should not be surprising, then, to see CYDY share price to be affected in the same way, if CYDY is lucky enough to get NASDAQ approval. The only difference may be that because of the share structure here, the reverse split may have a more significant impact.